Technische Universität München (TUM)

Competency in managing cardiac arrest: A scenario-based evaluation of dental students (2016) Breuer G, Knipfer C, Huber T, Hüttl S, Shams N, Knipfer K, Neukam FW, et al. Journal article Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial (2016) Herrlinger U, Schaefer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, et al. Journal article Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases (2016) Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, et al. Journal article Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients (2016) Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, et al. Journal article Resilience for Massively Parallel Multigrid Solvers (2016) Huber M, Gmeiner B, Rüde U, Wohlmuth BI Journal article, Original article Lattice Boltzmann methods in porous media simulations: From laminar to turbulent flow (2016) Fattahi E, Waluga C, Wohlmuth BI, Rüde U, Manhart M, Helmig R Journal article, Original article Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy (2016) Guckenberger M, Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, et al. Journal article Zirkeltraining für die Geschäftsentwicklung - der Gründerparcours als interaktives Format zur Förderung angehender Entrepreneure (2016) Möslein K, Fritzsche A, Bauer B, Schätz B, Schmidt J Conference contribution, other Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma (2016) Hedegaard J, Lamy P, Nordentoft I, Algaba F, Hoyer S, Ulhoi BP, Vang S, et al. Journal article Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial (2016) Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, et al. Journal article